Cite
MLA Citation
Kyoko Nitta et al.. “Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.” BioMed research international, vol. 2016, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100160446023.0x000009